Calibration of a whole blood sample analyser
CA 2322948 A1 · Owner: Wardlaw Partners Lp · Inventors: Wardlaw, Stephen C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Formed constituents of a quiescent anticoagulated whole blood sample are optically analyzed by an optical scanning instrument (54) which sample is , contained in a sample chamber (14) that has a varying through plane thickness. The thickness of any fields of view in the blood sample which contain plasma lacunae can be calculated by the instrument as a function of signal emission strength emanating from the colored plasma in the lacunae. The signal emissions can be the result of sample fluorescence or can be the result of signal density emanating from the sample. Particle volumes can be measured as a function of signal emission suppression which is caused by formed particles in the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 17, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 17, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 17, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.